00993cam1 22002533 450 SOBE0005315720160721093738.020160721d2000 |||||ita|0103 bafreFRDiapasonméthode de françaisBertrand Westphal, Grazia Bellano[s.l.]Lang Edizioni2000v.ill.29 cm001SOBE000531582000 Livre de l'élève / Bertrand Westphal, Grazia Bellano001SOBE000531592000 Cahier "écriture" : objectif production écrite / Bertrand Westphal, Grazia Bellano001SOBE000531602000 Cahier "civilisation" : objectif compréhnsion écrite / Bertrand Westphal, Grazia BellanoWestphal, BertrandAF00014492070148691BELLANO, GraziaAF00024182070148692ITUNISOB20160721RICASOBE00053157M 102 Monografia moderna SBNMDiapason1727184UNISOB05422nam 2201645z- 450 9910367743903321202102113-03921-655-4(CKB)4100000010106278(oapen)https://directory.doabooks.org/handle/20.500.12854/56155(oapen)doab56155(oapen)56155(EXLCZ)99410000001010627820202102d2019 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierPheochromocytoma (PHEO) and Paraganglioma (PGL)MDPI - Multidisciplinary Digital Publishing Institute20191 online resource (380 p.)3-03921-654-6 This book outlines some new advances in genetics, clinical evaluation, localization, therapy (newly including immunotherapy) of pheochromocytoma and paraganglioma including their metastatic counterparts. Well-known and experienced clinicians and scientists contributed to this book to include some novel approaches to these tumors. This book will serve to various health care professionals from different subspecialties, but mainly oncologists, endocrinologists, endocrine surgeons, pediatricians, and radiologists. This book shows that the field of pheochromocytoma/paraganglioma is evolving and a significant progress has been made in last 5 years requiring that health care professionals and scientists will learns new information and implement it in their clinical practice or scientific work, respectively. This book should not be missed by anybody who is focusing on neuroendocrine tumors, their newest evaluation and treatment.Pheochromocytoma Medicine and Nursingbicssc11C-hydroxy-ephedrine177Lu-DOTATATE18F-FDOPAadaptive immunityadrenal incidentalomaadrenal tumoradrenocortical carcinomaadrenomedullary functionangiogenesisarrhythmiaaverage real variabilityblood pressure variabilitycalorimetrycarotid bodycatecholaminecatecholamineschromogranin Achromosomal alterationCNV detectioncomparative genomicscryoablationdiabetes mellitusdogectopic secretionenergy metabolismEPAS1erythropoietinFGF21fluorescence imagingGAPPgermline mutationglobal longitudinal strainGTVhead and neckhereditaryHIFhistologyhypertensionhypotensionhypoxiahypoxia-inducible factorimmunohistochemistryimmunotherapyinflammationinnate immunitylL-6meta-analysismetanephrinesmetastaticmetastatic OR malignant pheochromocytomaminimally invasive proceduremitochondriamortalitymouse pheochromocytoma cellsmutationn/aNETneural crestneuroendocrineneuroendocrine tumorneurogenesisneutrophilnext-generation sequencingNF1normetanephrinesobesitypan-cancer analysisparagangliomaPASSpathogen-associated molecular patternsPCCpeptide receptor radiotherapypercutaneous ablationpercutaneous ethanol injectionPETPET-CTPGLpheochromocytomapheochromocytoma and paragangliomaphosphorylation tyrosine hydroxylasepolycythemiapostoperativePPGLPRRTpseudohypoxiaradiofrequency ablationradiosensitizationradiotherapySDHBSDHDsomatostatinomaspeckle-tracking echocardiographyspheroidssporadicstem-like tumor cellssubclinical systolic dysfunctionsuccinate dehydrogenaseT celltargeted therapyTCA cycletherapy resistancetoll-like receptortransgenic micevasculogenesisVHLweighted standard deviationxenograftMedicine and NursingPacak Karelauth881323Taïeb DavidauthBOOK9910367743903321Pheochromocytoma (PHEO) and Paraganglioma (PGL)3030537UNINA